• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过包合到SBA-15介孔二氧化硅材料中来提高水飞蓟宾的生物利用度。

Improving bioavailability of silybin by inclusion into SBA-15 mesoporous silica materials.

作者信息

Fu Tingming, Lu Jin, Guo Liwei, Zhang Lianjun, Cai Xueping, Zhu Huaxu

机构信息

College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210029, China.

出版信息

J Nanosci Nanotechnol. 2012 May;12(5):3997-4006. doi: 10.1166/jnn.2012.5826.

DOI:10.1166/jnn.2012.5826
PMID:22852339
Abstract

Mesoporous silica SBA-15 (SC) and template occluded SBA-15 (SP) were used to increase the bioavailability of silybin, an extremely poorly water soluble drug. Silybin was introduced into SC and SP by assembling or self-assembling methods. The results of X-ray powder diffraction, differential scanning calorimetry (DSC) and N2 adsorption-desorption experiment indicated that amorphous silybin was successfully introduced into the mesopores in both SC and SP samples. The transmission electron micrograph (TEM) images revealed that the structure of the mesoporous materials was not destroyed after the drug loading. Results of dissolution rate tests and animal experiments showed that both SC and SP can significantly improve the bioavailability of silybin, SP was thus preferred because the template needs not to be removed by calcination or extraction.

摘要

介孔二氧化硅SBA - 15(SC)和模板封闭的SBA - 15(SP)被用于提高水飞蓟宾的生物利用度,水飞蓟宾是一种水溶性极差的药物。通过组装或自组装方法将水飞蓟宾引入SC和SP中。X射线粉末衍射、差示扫描量热法(DSC)和N2吸附 - 脱附实验结果表明,无定形水飞蓟宾成功引入到SC和SP样品的介孔中。透射电子显微镜(TEM)图像显示,载药后介孔材料的结构未被破坏。溶出度试验和动物实验结果表明,SC和SP均可显著提高水飞蓟宾的生物利用度,因此SP更受青睐,因为无需通过煅烧或萃取去除模板。

相似文献

1
Improving bioavailability of silybin by inclusion into SBA-15 mesoporous silica materials.通过包合到SBA-15介孔二氧化硅材料中来提高水飞蓟宾的生物利用度。
J Nanosci Nanotechnol. 2012 May;12(5):3997-4006. doi: 10.1166/jnn.2012.5826.
2
Ketoprofen mesoporous silica nanoparticles SBA-15 hard gelatin capsules: preparation and in vitro/in vivo characterization.酮洛芬介孔二氧化硅纳米粒子SBA - 15硬明胶胶囊:制备及体外/体内表征
Drug Deliv. 2016 Nov;23(9):3387-3398. doi: 10.1080/10717544.2016.1186251. Epub 2016 Jun 3.
3
Formulation and optimization of drug-loaded mesoporous silica nanoparticle-based tablets to improve the dissolution rate of the poorly water-soluble drug silymarin.载药介孔硅纳米粒片的处方前研究及其优化:提高疏水性药物水飞蓟宾溶出度的新方法。
Eur J Pharm Sci. 2020 Jan 15;142:105103. doi: 10.1016/j.ejps.2019.105103. Epub 2019 Oct 21.
4
Stable and Fast-Dissolving Amorphous Drug Composites Preparation via Impregnation of Neusilin UFL2.通过 Neusilin UFL2 浸渍法制备稳定且快速溶解的无定形药物复合材料。
J Pharm Sci. 2018 Jan;107(1):170-182. doi: 10.1016/j.xphs.2017.10.007. Epub 2017 Oct 13.
5
Dissolution enhancement of a model poorly water-soluble drug, atorvastatin, with ordered mesoporous silica: comparison of MSF with SBA-15 as drug carriers.有序介孔二氧化硅对模型难溶性药物阿托伐他汀的溶出增强作用:以MSF和SBA - 15作为药物载体的比较
Expert Opin Drug Deliv. 2016;13(2):171-81. doi: 10.1517/17425247.2015.1111335. Epub 2015 Dec 4.
6
Improved solubility of lornoxicam by inclusion into SBA-15: Comparison of loading methods.洛索洛芬包载入 SBA-15 后溶解度提高:负载方法比较。
Eur J Pharm Sci. 2022 Apr 1;171:106133. doi: 10.1016/j.ejps.2022.106133. Epub 2022 Jan 21.
7
A novel strategy to design sustained-release poorly water-soluble drug mesoporous silica microparticles based on supercritical fluid technique.基于超临界流体技术设计缓控释难溶性药物介孔硅微球的新策略。
Int J Pharm. 2013 Sep 15;454(1):135-42. doi: 10.1016/j.ijpharm.2013.07.027. Epub 2013 Jul 17.
8
In vitro release and in vitro-in vivo correlation for silybin meglumine incorporated into hollow-type mesoporous silica nanoparticles.水飞蓟宾葡甲胺载入中空型介孔硅纳米粒子的体外释放度和体外-体内相关性研究。
Int J Nanomedicine. 2012;7:753-62. doi: 10.2147/IJN.S28348. Epub 2012 Feb 14.
9
Candesartan Cilexetil Formulations in Mesoporous Silica: Preparation, Enhanced Dissolution In Vitro, and Oral Bioavailability In Vivo.坎地沙坦西酯介孔硅药物制剂:制备、体外增溶及体内口服生物利用度。
J Pharm Sci. 2024 Oct;113(10):3045-3053. doi: 10.1016/j.xphs.2024.07.007. Epub 2024 Aug 2.
10
Nanoconfinement of a Pharmaceutical Cocrystal with Praziquantel in Mesoporous Silica: The Influence of the Solid Form on Dissolution Enhancement.介孔硅纳米限域下吡喹酮药物共晶的形成:固体形态对溶出增强的影响。
Mol Pharm. 2022 Feb 7;19(2):414-431. doi: 10.1021/acs.molpharmaceut.1c00606. Epub 2021 Dec 30.

引用本文的文献

1
Mesoporous silica nanoparticles, a safe option for silymarin delivery: preparation, characterization, and in vivo evaluation.介孔硅纳米颗粒,水飞蓟宾传递的安全选择:制备、表征和体内评价。
Drug Deliv Transl Res. 2019 Oct;9(5):968-979. doi: 10.1007/s13346-019-00640-3.